The HSC niche concept has turned 31: Has our knowledgematured?

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 12-18

  Lymperi, Stefania ^a   Ferraro, Francesca ^a   Scadden, David T ^a  

^a Harvard University   (United States)

Author keywords

HSC niche; Microenvironment; Osteoblastic cells; Perivascular cells; Regeneration; Stem cells

Indexed keywords

CYTOKINE; GROWTH FACTOR; OSTEOPONTIN; SCLEROPROTEIN;

CANCER STEM CELL; CELL FATE; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; MICROENVIRONMENT; NONHUMAN; OSTEOBLAST; STROMA CELL; VASCULAR TISSUE;

EID: 77950658719     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05223.x     Document Type: Conference Paper

References (40)

1. Schofield, R. 1978. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4: 7-25.
2. Xie, T. & A.C. Spradling. 1998. Decapentaplegic is essential for the maintenance and division of germline stem cells in the Drosophila ovary. Cell 94: 251-260.
3. Lord, B.I., N.G. Testa & J.H. Hendry. 1975. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 46: 65-72.
4. Taichman, R.S., M.J. Reilly & S.G. Emerson. 1996. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 87: 518-524.
5. Stier, S. et al. 2005. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201: 1781-1791.
6. Nilsson, S.K. et al. 2005. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106: 1232-1239.
7. Arai, F. et al. 2004. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118: 149-161.
8. Yoshihara, H. et al. 2007. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1: 685-697.
9. Calvi, L.M. et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
10. Zhang, J. et al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836-841.
11. Visnjic, D. et al. 2004. Hematopoiesis is severely altered in micewith an induced osteoblast deficiency. Blood 103: 3258-3264.
12. Lymperi, S. et al. 2008. Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood 111: 1173-1181.
13. Kiel, M.J., G.L. Radice & S.J. Morrison. 2007. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 1: 204-217.
14. DiMascio, L. et al. 2007. Identification of adiponectin as a novel hemopoietic stemcell growth factor. J. Immunol. 178: 3511-3520.
15. Naveiras, O. et al. 2009. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460: 259-263.
16. Kollet,O. et al. 2006. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12: 657-664.
17. Adams, G.B. et al. 2006. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439: 599-603.
18. Kennedy,M. et al. 1997. A common precursor for primitive erythropoiesis and definitive haematopoiesis.Nature 386: 488-493.
19. Taniguchi,H. et al. 1996. Presence of hematopoietic stem cells in the adult liver. Nat. Med. 2: 198-203.
20. Kiel, M.J. et al. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109-1121.
21. Sipkins, D.A. et al. 2005. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435: 969-973.
22. Avecilla, S.T. et al. 2004. Chemokine-mediated interaction of hematopoietic progenitorswith the bone marrow vascular niche is required for thrombopoiesis. Nat.Med. 10: 64-71.
23. Yao, L. et al. 2005. Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells. Blood 106: 4093-4101.
24. Sacchetti, B. et al. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336.
25. Lo Celso, C. et al. 2009. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457: 92-96.
26. Goodman, J.W. & G.S.Hodgson. 1962. Evidence for stem cells in the peripheral blood of mice. Blood 19: 702-714.
27. Levesque, J. et al. 2001. Vascular cell adhesionmolecule- 1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98: 1289-1297.
28. Petit, I. et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3: 687-694.
29. Shen,H. et al. 2001. CXCR4 desensitization is associated with tissue localization of hemopoietic prgenitor cells. J. Immunol. 166: 5027-5033.
30. Calandra, G. et al. 2008. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failingmobilizationwith chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant. 41: 331-338.
31. Katayama, Y. et al. 2006. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124: 407-421.
32. Mendez-Ferrer, S. et al. 2008. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452: 442-447.
33. Askari, A.T. et al. 2003. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703.
34. Simmons,D.J.& G.Nichols, Jr. 1966. Diurnal periodicity in the metabolic activity of bone tissue. Am. J. Physiol. 210: 411-418.
35. Bendall, L.J., K. Kortlepel & D.J. Gottlieb. 1993. Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms. Blood 82: 3125-3132.
36. Flynn, C.M. & D.S. Kaufman. 2007. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood 109: 2688-2692.
37. Walkley, C.R. et al. 2007. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129: 1097-1110.
38. Adams, G.B. et al. 2007. Therapeutic targeting of a stem cell niche. Nat. Biotechnol. 25: 238-243.
39. Adams, G.B. et al. 2009. Haematopoietic stem cells depend on Galpha(s)-mediated signalling to engraft bone marrow. Nature 459: 103-107.
40. Hoggatt, J. et al. 2009. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113: 5444-5455.